Status:
COMPLETED
Use of SV40 Vectors to Treat Chronic Myeloid Leukemia (CML)
Lead Sponsor:
Hadassah Medical Organization
Collaborating Sponsors:
United States Department of Defense
Conditions:
Chronic Myeloid Leukemia
Eligibility:
All Genders
18+ years
Brief Summary
Chronic myeloid leukemia is a serious disease which is characterized by progression from relatively quiescent stages of the disease to an aggressive phase. Although now there is highly successful medi...
Detailed Description
A novel methodology that facilitates specific silencing of genes has recently been developed. The method is based on the property of small molecules of nucleic acids (RNA) to specifically repress expr...
Eligibility Criteria
Inclusion
- Diagnosis of CML
Exclusion
- Under 18 years old
- Pregnant
Key Trial Info
Start Date :
September 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2007
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00257647
Start Date
September 1 2005
End Date
November 1 2007
Last Update
February 18 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical Organization
Jerusalem, Israel, IL91120